Smitha Zaharoff

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial

Nicholas Turner, Smitha Zaharoff, Heather A. King et al. · Trials · 2022 · 51 citations · Full text

Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers

Thomas P. Lodise, J. Nicholas O’Donnell, Shruti M. Raja et al. · Antimicrobial Agents and Chemotherapy · 2022 · 20 citations · Full text

Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults

Thomas P. Lodise, J. Nicholas O’Donnell, Stephen J. Balevic et al. · Antimicrobial Agents and Chemotherapy · 2022 · 20 citations · Full text

Dalbavancin for Treatment of <i>Staphylococcus aureus</i> Bacteremia

Nicholas Turner, Toshimitsu Hamasaki, Sarah B. Doernberg et al. · JAMA · 2025 · 18 citations · Full text

Determination of plasma protein binding of dalbavancin

Nicholas Turner, Allan Xu, Smitha Zaharoff et al. · Journal of Antimicrobial Chemotherapy · 2022 · 13 citations · Full text